The 21 European Biotech Companies to Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection…
A drug designed by the UK firm Exscientia using AI-powered software has entered into a…
In a deal with €22M paid upfront and undisclosed “substantial milestones and royalties,” Exscientia will…
Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with…
Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with…
After Sanofi recruited Exscientia in a €250M deal last May, GSK has taken an interest in…
As part of the deal with Sanofi, Exscientia will tackle the discovery and design of…